Mangurian, C. V., and L. A. Bero. 2000. Lessons learned from the tobacco industry’s efforts to prevent the passage of a workplace smoking regulation. American Journal of Public Health 90(12):1926–1930.
Markowitz, L. E., E. Dunne, M. Saraiya, H. Lawson, H. Chesson, and E. Unger. 2007. Quadrivalent human papillomavirus vaccine. Morbidity and Mortality Weekly Report 56(RR02):1–24.
Miller, C., M. Wakefield, S. Kriven, and A. Hyland. 2002. Evaluation of smoke-free dining in South Australia: Support and compliance among the community and restauranteurs. Australia and New Zealand Journal of Public Health 26(1):38–44.
Muggli, M. E., R. D. Hurt, and D. D. Blanke. 2003. Science for hire: A tobacco industry strategy to influence public opinion on secondhand smoke. Nicotine and Tobacco Research 5(3):303–314.
Neustadt, R. E., and H. V. Fineberg. 1978. The swine flu affair: Decision-making on a slippery disease. Washington, DC: National Academy Press.
Nissen, S. E., and K. Wolski. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine 356(24):2457–2471.
NRC (Nuclear Regulatory Commission). 2012. Risk assessment in regulation. http://www.nrc.gov/about-nrc/regulatory/risk-informed.html (accessed January 3, 2013).
NTP (National Toxicology Program). 2011. Report on carcinogens, twelfth edition. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf (accessed January 2, 2013).
Ong, E. K., and S. A. Glantz. 2000. Tobacco industry efforts subverting International Agency for Research on Cancer’s second-hand smoke study. Lancet 355(9211):1253–1259.
Oreskes, N., and E. M. Conway. 2010. Merchants of doubt: How a handful of scientists obscured the truth on issues from tobacco smoke to global warming. New York: Bloomberg Press.
Pell, J. P., S. Haw, S. Cobbe, D. E. Newby, A. C. H. Pell, C. Fischbacher, A. McConnachie, S. Pringle, D. Murdoch, and F. Dunn. 2008. Smoke-free legislation and hospitalizations for acute coronary syndrome. New England Journal of Medicine 359(5):482–491.
Petter, A., K. Heim, M. Guger, A. Ciresa–König, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl. 2000. Specific serum IGG, IGM and IGA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. Journal of General Virology 81(3):701–708.
Pursell, L., S. Allwright, D. O’Donovan, G. Paul, A. Kelly, B. J. Mullally, and M. D’Eath. 2007. Before and after study of bar workers’ perceptions of the impact of smoke-free workplace legislation in the republic of Ireland. BMC Public Health 7:131.
Sanders, G. D., and A. V. Taira. 2003. Cost effectiveness of a potential vaccine for human papillomavirus. Emerging Infectious Diseases 9(1):37–48.
Sargent, R. P., R. M. Shepard, and S. A. Glantz. 2004. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: Before and after study. British Medical Journal 328(7446):977–980.
Scallan, E., R. M. Hoekstra, F. J. Angulo, R. V. Tauxe, M. A. Widdowson, S. L. Roy, J. L. Jones, and P. M. Griffin. 2011. Foodborne illness acquired in the United States—Major pathogens. Emerging and Infectious Diseases 17(1):7–15.
Sciacca, J. P., and M. I. Ratliff. 1998. Prohibiting smoking in restaurants: Effects on restaurant sales. American Journal of Health Promotion 12(3):176–184.
Scollo, M., A. Lal, A. Hyland, and S. Glantz. 2003. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tobacco Control 12(1):13–20.